Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.

Clinical trial NCT05817110 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05817110
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Lung Malignancy

Start date: 2023-04-20
Primary completion: 2026-12-06
Enrollment: 712

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.